Literature DB >> 26719566

Clinical Mass Spectrometry-Achieving Prominence in Laboratory Medicine.

Thomas M Annesley1, R Graham Cooks2, David A Herold3, Andrew N Hoofnagle4.   

Abstract

Mesh:

Year:  2016        PMID: 26719566     DOI: 10.1373/clinchem.2015.251272

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  3 in total

Review 1.  Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.

Authors:  Johanna Kuhlin; Marieke G G Sturkenboom; Samiksha Ghimire; Ioana Margineanu; Simone H J van den Elsen; Noviana Simbar; Onno W Akkerman; Erwin M Jongedijk; Remco A Koster; Judith Bruchfeld; Daan J Touw; Jan-Willem C Alffenaar
Journal:  Clin Mass Spectrom       Date:  2018-10-19

2.  Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Richard G Ivey; Marilyn Sanchez-Bonilla; Heather D Moore; Regine M Schoenherr; Ping Yan; Chenwei Lin; Akiko Shimamura; Amanda G Paulovich
Journal:  DNA Repair (Amst)       Date:  2018-03-21

3.  A photocleavable peptide-tagged mass probe for chemical mapping of epidermal growth factor receptor 2 (HER2) in human cancer cells.

Authors:  Liang Liu; Yuqiong Kuang; Zhongcheng Wang; Yun Chen
Journal:  Chem Sci       Date:  2020-09-30       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.